ADVI's Lindsay Bealor Greenleaf spoke to BioWorld about the latest congressional scrutiny around prescription drug list price increases and the overlooked role played by pharmacy benefit managers.

In The News,

Mar 08 2022

ADVI’s Lindsay Bealor Greenleaf spoke to BioWorld about the latest congressional scrutiny around prescription drug list price increases and the overlooked role played by pharmacy benefit managers.

March 8, 2022, ADVI’s Lindsay Bealor Greenleaf spoke to BioWorld about the latest congressional scrutiny around prescription drug list price increases and the overlooked role played by pharmacy benefit managers.
Read the full article here